Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Planning Committee Disclosures
Fabrizio Michelassi, MD, FACS, MAMSE - Tsumura, Inc.
Sharmila Dissanaike, MD, FACS, FCCM - Heron Therapeutics
Brooke C. Bredbeck, MD - Nothing to disclose
Kellie R. Brown, MD, FACS - Nothing to disclose
Yolanda L. Colson, MD, PhD, FACS - Canon USA; Stryker
Cynthia D. Downard, MD, MMSc, FACS, FAAP - Nothing to disclose
Quan-Yang Duh, MD, FACS - Nothing to disclose
Neal D. Futran, MD, DMD, FACS - Stryker
B.J. Hancock, MD, FRCSC, FACS - Nothing to disclose
Jonathan A. Laryea, MBChB, FACS, FASCRS, FWACS - Nothing to disclose
Amy E. Liepert, MD, FACS - Nothing to disclose
Ronald V. Maier, MD, FACS, FRCSED(Hon), FCSHK(Hon), FCCS(Hon), FISS(Hon), MAMSE - Nothing to disclose
Viraj Master, MD, PhD, FACS - Ethicon; Exelixis
Nipun B. Merchant, MD, FACS - Nothing to disclose
Susan C. Modesitt, MD, FACOG, FACS - Nothing to disclose
Lena Napolitano, MD FACS, MAMSE - Nothing to disclose
M. Timothy Nelson, MD, FACS, DABS - Nothing to disclose
Patrick R. Reardon, MD, FACS - Nothing to disclose
Kenneth W. Sharp, MD, FACS, MAMSE - Nothing to disclose
Ali Tavakkoli, MBBS, FACS - AltrixBio
Steve D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg), Hon FRCS (Eng), MAMSE - Baxter; BD (Becton, Dickinson & Co); Glaxo Smith Kline; Intuitive Surgical; Livsmed; Medtronic; OstomyCure; Stryker; Takeda; Virtual Ports; JSR/WCG/ACI; Polypid; Boomerang; Intuitive Surgical; Karl Storz Endoscopy America Inc; Unique Surgical Innovations LLC; Pragma/GibLib; Renew Medical
Speakers/Faculty Disclosures
Catherine E. Pesce, MD, FACS – Nothing to disclose
Rachel A. Greenup, MD, FACS – AstraZeneca
Ton Wang, MD – Nothing to disclose
Olga Kantor, MD, FACS – Nothing to disclose
Kristalyn Gallagher, DO, FACS – Endomag
Thomas Smith, MD – Nothing to disclose
